Crystalline forms of 5-chloro-6- (2, 6-difluoro-4- [3- (methylamino) propoxy] phenyl)-N-((1S)-2, 2, 2,-trifluoro-1-methylethyl] [1,2,4] triazolo [1,5-a] pyrimidin-7-amine salts

Details for Australian Patent Application No. 2007254258 (hide)

Owner Wyeth Holdings Corporation

Inventors Wu, Yanzhong; Blum, David M.; Qi, Fang Fang; Ku, Mannching Sherry

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007254258

PCT Pub. Number WO2007/136692

Priority 11/437,291 19.05.06 US

Filing date 17 May 2007

Wipo publication date 29 November 2007

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/04 (2006.01) Antineoplastic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/136692 Priority application(s): WO2007/136692

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007254259-Prediction of relative polypeptide solubility by polyethylene glycol precipitation

2007254255-Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor